Safety of RSV Preventive Monoclonal Antibody

Clinical trial NCT07158814 · RECRUITING

Trial details

NCT number: NCT07158814
Sponsor: Duke University
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Fever Adverse Event Following Immunisation

Start date: 2025-10-02
Primary completion: 2027-02-01
Enrollment: 524

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.